WebDec 17, 2024 · Pascal Rigollier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already … WebOct 8, 2008 · RIGOLLIER PASCAL, YIFRU AREGAHEGN. Author information. Affiliations. All authors. 1. NOVARTIS AG, Patent: Publ.of the Int.Appl. with Int.search report - World Intellectual Property Organization Application: WO2008EP63460 on 08 Oct 2008 Publication: 08 Oct 2008 PAT: WO2009047264 ...
Target identification for a Hedgehog pathway inhibitor reveals the ...
WebApr 11, 2024 · Corpus ID: 248099592 Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent and Selective, Covalent Oral Inhibitor of KRASG12C. A. Weiss, E. Lorthiois, +36 authors S. Brachmann Published 11 April 2024 Biology, Chemistry Cancer discovery WebApr 9, 2007 · Filed: April 9, 2007 Publication date: November 15, 2007 Inventors: Sylvain Cottens, Claus Ehrhardt, Jiping Fu, David Parker, Michael Patane, Branko Radetich, Prakash Raman, Stefan Randl, Pascal Rigollier, Mohindra Seepersaud, Oliver Simic, Dongpeng Wan medival oak house minecraft
SPIROPYRROLIDINES AND THEIR USE AGAINST HCV AND …
WebMay 1, 2014 · A series of cyclohexyl-methyl aminopyrimidine chemotype compounds ('CMAPs') were identified that could block pathway signaling in a Smo-independent manner. In addition to inhibiting Hh signaling, the compounds generated inositol phosphates through an unknown GPCR. Correlation of GPCR mRNA expression… View on PubMed doi.org … WebSep 20, 2010 · Andreas Boettcher, Simon Ruedisser, Paulus Erbel, Daniela Vinzenz, Nikolaus Schiering, Ulrich Hassiepen, Pascal Rigollier, Lorenz M. Mayr, and Julian … WebPascal Rigollier is on Facebook. Join Facebook to connect with Pascal Rigollier and others you may know. Facebook gives people the power to share and makes the world … medival shield testing